verónica torrano moya
University of the Basque Country
Bilbao, Spain
Review Editor
Pharmacology of Anti-Cancer Drugs
Editors
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
jose trevino
Virginia Commonwealth University
Richmond, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
tushar trivedi
Regional Medical Center
Orangeburg, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
tushar trivedi
Regional Medical Center
Orangeburg, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
jian tu
Guilin Medical University
Guilin, China
Review Editor
Pharmacology of Anti-Cancer Drugs
murali venkata basavanag unnamatla
Universidad Autónoma del Estado de México
Toluca, Mexico
Review Editor
Pharmacology of Anti-Cancer Drugs
md. hafiz uddin
Wayne State University
Detroit, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
yasuhito uezono
Jikei University School of Medicine
Minato, Japan
Review Editor
Pharmacology of Anti-Cancer Drugs
federica vacondio
University of Parma
Parma, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
suresh valiyaveettil
National University of Singapore
Singapore, Singapore
Review Editor
Pharmacology of Anti-Cancer Drugs
luis alberto vallejo-castillo
National Polytechnic Institute (IPN)
Mexico City, Mexico
Review Editor
Pharmacology of Anti-Cancer Drugs
maryna van de venter
Nelson Mandela University
Port Elizabeth, South Africa
Review Editor
Pharmacology of Anti-Cancer Drugs
adam vanwert
Wilkes University
Wilkes-Barre, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
marianela vara messler
Université Catholique de Louvain
Louvain-la-Neuve, Belgium
Review Editor
Pharmacology of Anti-Cancer Drugs
pegah varamini
The University of Sydney
Darlington, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs
olga vasiljeva
CytomX Therapeutics Inc
South San Francisco, United States
Review Editor
Pharmacology of Anti-Cancer Drugs